Skip to Main Content

Paper Details

Ensifentrine, a Novel Phosphodiesterase 3 and 4 Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease: Randomized, Double-Blind, Placebo-controlled, Multicenter Phase III Trials (the ENHANCE Trials).
Am J Respir Crit Care Med
12
2023
Author NameAffiliation
Antonio Anzueto
Antonio AnzuetoUniversity of Texas Health
Frank C SciurbaUniversity of Pittsburgh
  • 1 - 3

Datasets

Release 1.2